EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives

A. Tzikas, T. Lewalter

Continuing Cardiology Education · 2016

DOI: 10.1002/cce2.18 ↗
AstrattDettalji biblijografiċi

Astratt

Abstract Left atrial appendage occlusion (LAAO) is a promising alternative to oral anti‐coagulation in patients with non‐valvular atrial fibrillation. Recently, four‐year results of PROTECT‐AF demonstrated superiority of LAAO in all‐cause mortality and stroke reduction compared to optimal medical treatment with warfarin. In this new era, it is important to identify the patients who would benefit more from LAAO and offer them priority for treatment. Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/4193475/Activity.aspx

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →